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PCARDIOVASCULAR RISK
A High Ankle Brachial Index Is
Associated With Greater Left Ventricular Mass
MESA (Multi-Ethnic Study of Atherosclerosis)
Joachim H. Ix, MD, MAS,*†‡ Ronit Katz, DPHIL,§ Carmen A. Peralta, MD, MAS,#**
Ian H. de Boer, MD, MS, Matthew A. Allison, MD, MPH,† David A. Bluemke, MD, PHD,††
David S. Siscovick, MD, MPH,¶ João A. C. Lima, MD,‡‡ Michael H. Criqui, MD, MPH†
San Diego and San Francisco, California; Seattle, Washington; and Bethesda and Baltimore, Maryland
Objectives This study sought to determine the association of high ankle brachial index (ABI) measurements with left ven-
tricular (LV) mass, and to compare its strength with that of low ABI with LV mass.
Background Arterial stiffness leads to LV mass through nonatherosclerotic pathways in mice. In humans, a high ABI indicates
stiff peripheral arteries and is associated with cardiovascular disease (CVD) events. Whether high ABI is associ-
ated with LV mass in humans and whether this might reflect consequences of arterial stiffness, atherosclerosis,
or both is unknown.
Methods Among 4,972 MESA (Multi-Ethnic Study of Atherosclerosis) participants without clinical CVD, we used linear re-
gression to evaluate the association of low (0.90) and high (1.40 or incompressible) ABI with LV mass by
cardiac magnetic resonance imaging (MRI). Intermediate ABIs served as the reference category. To determine
the effect of subclinical atherosclerosis, models were adjusted for common and internal carotid intima media
thickness (cIMT) and natural log-transformed coronary artery calcification.
Results Compared with subjects with intermediate ABI, LV mass was higher with either low (2.70 g/m2 higher, 95% con-
fidence interval: 0.65 to 4.75) or high ABI (6.84 g/m2 higher, 95% confidence interval: 3.2 to 10.47) after ad-
justment for traditional CVD risk factors, kidney function, and C-reactive protein. However, further adjustment for
cIMT and CAC substantially attenuated the association of low ABI with LV mass index (1.24 g/m2 higher, 95%
confidence interval: 0.84 to 3.33), whereas the association of high ABI was minimally altered (6.01 g/m2
higher, 95% confidence interval: 2.36 to 9.67).
Conclusions High ABI is associated with greater LV mass; an association that is not attenuated with adjustment for subclinical
atherosclerosis in nonperipheral arterial beds. High ABI might lead to greater LV mass through nonatherosclerotic
pathways. (J Am Coll Cardiol 2010;55:342–9) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.010c
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Mhe ankle brachial index (ABI) is a simple noninvasive
est, reflecting the ratio of the systolic blood pressure
SBP) in the ankle divided by SBP in the brachial artery.
ow ABI measurements (0.90) have been studied as a
arker of atherosclerotic peripheral arterial disease
PAD) for over 40 years (1). The cardiovascular disease
CVD) consequences of high ABI measurements are less
ell-studied.
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rancisco, San Francisco, California; **San Francisco Veterans Affairs Medical Center, aWhereas low ABI measurements are sensitive and spe-
ific for flow-limiting atherosclerotic PAD (2), high ABI
easurements occur when the lower limb arteries are stiff,
herefore requiring higher cuff pressures to occlude the
eripheral arteries. This is widely believed to occur as a
onsequence of a vascular pathology distinct from athero-
clerosis, medial arterial calcification (MAC) (3–5). In
utopsy studies, MAC is limited to the arterial media as
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January 26, 2010:342–9 High Ankle Brachial Index and LV Massompared with the intimal location of atherosclerosis, is
oninflammatory, and is not associated with lipid plaque
6,7). Recently, Resnick et al. (8) demonstrated a U-shaped
elationship between ABI measurements and CVD events in
ommunity-living Native Americans. Subjects with either high
r low ABI were at approximately equal risk for CVD events,
nd either extreme was at approximately 2-fold risk compared
ith persons with intermediate ABI. This finding has since
een confirmed in several other community-based cohorts
9,10) and has been extended to include incident congestive
eart failure (CHF) events (10,11).
The mechanisms responsible for these associations are
nknown. One potential mechanism might be through myo-
ardial remodeling, as a consequence of arterial stiffness.
ndeed, experimentally induced MAC in rats led to greater
rterial stiffness and left ventricular (LV) mass (12). Alterna-
ively, the association of high ABI with CVD events might be
ue to co-existing atherosclerosis, because prior studies have
emonstrated that both diseases might co-exist within individ-
als (13–15).
Here, we evaluate the association of high ABI measure-
ents with LV mass by cardiac magnetic resonance imaging
MRI) in the MESA (Multi-Ethnic Study of Atheroscle-
osis). We compare the strength of this association with that
f low ABI and LV mass. On the basis of the experimental
nimal data, we hypothesized that the association of high
BI with LV mass would be independent of traditional
VD risk factors and would not be significantly attenuated
fter adjustment for subclinical atherosclerosis in other
rterial beds.
ethods
articipants. MESA was initiated to investigate the prev-
lence and progression of subclinical CVD. Details about
he study design have been published previously (16). In
rief, between July 2000 and August 2002, 6,814 men and
omen age 45 to 84 years who identified themselves as
aucasian, African-American, Hispanic, or Chinese and
ere free of clinically apparent CVD were recruited from 6
.S. communities: Baltimore, Maryland; Chicago, Illinois;
orsyth County, North Carolina; Los Angeles, California;
orthern Manhattan and the Bronx, New York; and St.
aul, Minnesota. Individuals were excluded if they had
hysician-diagnosed heart attack; angina; heart failure;
troke, or transient ischemic attack; atrial fibrillation; or
ndergone coronary artery bypass grafting, angioplasty, or
alve replacement. The patients were not screened for
laudication. The institutional review boards at each partic-
pating center approved the study, and participants provided
ritten informed consent.
All participants underwent a day-long study visit where
hey provided medical history, venous blood specimens after
n overnight (8-h) fast, spot urine specimens, and physical
xamination. In addition, participants underwent a detailed
valuation for subclinical atherosclerosis, which included fBI, thoracic computed tomog-
aphy (CT) for coronary artery
alcification (CAC), carotid ul-
rasound for common and inter-
al carotid intima media thick-
ess (cIMT), and cardiac MRI
or evaluation of LV mass and
unction.
For this study, we excluded
ubjects who did not undergo
ardiac MRI (n  1,716), had
echnically inadequate cardiac
RI data (n  94), or did not
rovide ABI measurements (n 
2), resulting in a final analytic
ample of 4,972 (73% of MESA
articipants).
easurements. ABI. After the
articipants had rested supine for
min, SBP was measured in
oth arms. For each leg, the SBP
n the posterior tibial and dorsalis
edis artery were measured with
ontinuous-wave Doppler ultra-
ound probes. The leg-specific
BI was calculated as the higher
BP in the posterior tibial or
orsalis pedis artery divided by
he higher of the 2 arm SBPs. The higher arm SBP was
sed because of the strong association between PAD and
ubclavian artery stenosis (17). Subject-specific ABIs were
efined by the lower of their 2 leg-specific ABI measure-
ents. If leg blood pressure could not be abolished with the
uff inflated to300 mm Hg, subjects were deemed to have
ncompressible peripheral arteries.
ARDIAC MRI MEASUREMENTS. Consenting participants
nderwent cardiac MRI scans a median of 16 days after the
aseline examination, and 95% were completed by 11 weeks
fter the baseline visit. The MRI scans were performed with
.5-T magnets with determination of LV mass and volumes
s previously described (18). The epicardial and endocardial
yocardial borders were contoured with a semi-automated
ethod (MASS version 4.2, Medis, Leiden, the Nether-
ands). The difference between the epicardial and endocar-
ial areas were multiplied by the slice thickness and section
ap and then multiplied by the specific gravity of the
yocardium (1.05 g/ml) to determine LV mass. The LV
ass was indexed to body surface area, calculated by the
uBois and DuBois formula (19). In similar fashion, left
entricular end-diastolic volume (LVEDV) and left ventric-
lar end-systolic volume (LVESV) were calculated by sum-
ation of the areas of separate slices, multiplied by the sum
f slice thickness and image gap. Stroke volume was
alculated as: LVEDV  LVESV. Left ventricular ejection
Abbreviations
and Acronyms
ABI  ankle brachial index
CAC  coronary artery
calcification
CHF  congestive heart
failure
cIMT  carotid intima
media thickness
CRP  C-reactive protein
CVD  cardiovascular
disease
LV  left ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
MAC  medial arterial
calcification
MRI  magnetic resonance
imaging
PAD  peripheral arterial
disease
SBP  systolic blood
pressureraction (LVEF) was calculated as stroke volume divided by
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High Ankle Brachial Index and LV Mass January 26, 2010:342–9VEDV multiplied by 100. We evaluated these parameters
n addition to LV mass/LVEDV (mass/volume ratio); a
easure of concentric cardiac remodeling (20).
Seventy-nine participants had repeat cardiac MRI mea-
urements 3 to 6 months after the initial measurement.
nalysis showed the technical error (expressed as percentage
f the mean value) was 6% and 4% for LV mass and
VEDV, respectively. The intraclass correlation coefficients
ere 0.98 and 0.98, respectively (18).
UBCLINICAL ATHEROSCLEROSIS MEASURES. Coronary ar-
ery calcification was assessed by thoracic CT with either a
ardiac-gated electron-beam CT scanner (Chicago, Los
ngeles, and New York field centers) or a multidetector CT
ystem (Baltimore, Forsyth County, and St. Paul field
enters). All participants were scanned twice. A phantom of
nown physical calcium concentration was included in the
eld of view. A radiologist or cardiologist read all CT scans
t a central reading center at Harbor–UCLA Medical
enter. The CAC was identified and quantified from
mages calibrated according to the readings of the calcium
hantom. The Agatston score was determined from plaque
ensities in all coronary arteries (21). The mean phantom-
djusted Agatston score was used for the 2 scans in all
nalyses. Carr et al. (22) have reported the details of the
ESA CT scanning and interpretation methods. Trained
echnicians performed B-mode ultrasonography of the near
nd far walls of the internal and common carotid arteries
ilaterally with a Logiq 700 ultrasound (General Electric,
aukesha, Wisconsin) (23,24). Images were read centrally
t Tufts-New England Medical Center. Maximal cIMT at
ach site was determined as previously described (24).
THER MEASUREMENTS. Standardized questionnaires were
sed to obtain information on medical history, race/
thnicity, and medication use. Hypertension was defined as
SBP140 mm Hg, diastolic blood pressure90 mm Hg,
r current use of antihypertensive medication. Diabetes
ellitus was defined as a fasting glucose 126 mg/dl or use
f hypoglycemic medications (25). Smoking was defined as
urrent, former, or never. Height and weight were measured
ith participants wearing light clothing and no shoes, and
ody mass index was calculated (in kg/m2). Resting blood
ressure was measured 3 times with participants in the
eated position with a Dinamap model Pro 100 automated
scillometric sphygmomanometer (Critikon, Tampa, Flor-
da). The average of the last 2 measurements was used in
nalyses. Total and high-density lipoprotein cholesterol and
riglyceride concentrations were measured from fasting ve-
ous blood samples. Low-density lipoprotein cholesterol
oncentration was calculated from the Friedewald equation
26). C-reactive protein (CRP) was measured with the BNII
ephelometer (N High Sensitivity CRP, Dade Behring, Inc.,
eerfield, Illinois). Serum creatinine was measured with a
olorimetric method by a Kodak Ektachem 700 Analyzer
Eastman Kodak, Rochester, New York) and was standard-
zed to the Cleveland Clinic Foundation reference standard aor direct calibration. Creatinine, age, sex, and race were
sed to calculate estimated glomerular filtration rate with
he abbreviated Modification of Diet in Renal Disease
ormula (27). Urine albumin and creatinine were measured
y nephelometry and the rate Jaffe reaction, respectively.
pot urine albumin/creatinine ratios were calculated.
tatistical analyses. Previous studies have consistently
emonstrated that subjects with ABI 0.90 and 1.40 or
ncompressible arteries are at greater risk for CVD events
nd mortality than subjects with intermediate ABI measure-
ents (8,10). We categorized subjects according to these
ut-points a priori. Baseline differences in demographic and
linical variables were compared across ABI groups with
nalysis of variance (ANOVA) for continuous variables and
he chi-square test for categorical variables. For continuous
ariables, when Bartlett’s test for equal variance was violated
p  0.05), the Kruskal-Wallis test was used in place of
NOVA; and when the expected number in any cell for
ategorical variables was10, the Fisher exact test was used
n place of the chi-square test. Linear regression analysis was
sed to evaluate the association of ABI categories with LV
ass/body surface area. Sequential models were developed.
odel 1 was adjusted for age, sex, race/ethnicity, and field
enter site. Candidate covariates for model 2 were all those
isted in Table 1, except for the subclinical atherosclerosis
easures. Among these, variables were retained in model 2,
f statistically significant differences were observed across
BI categories in bivariate analysis (p  0.05). Finally,
odel 3 included all model-2 variables plus the 3 markers of
ubclinical atherosclerosis (common cIMT, internal cIMT,
nd natural log-transformed coronary artery calcification).
f participants in this study, 48% had some CAC (score
0), and among these, CAC scores were strongly right-
kewed. We adjusted for CAC on a continuous scale by
dding 1 to CAC scores and naturally log-transformed the
esulting variable. Both common and internal cIMT scores
ere approximately normally distributed and were modeled
s continuous (un-transformed) covariates. To evaluate
ossible co-linearity, we evaluated the Pearson correlation
etween common cIMT and internal cIMT (r 0.41), thus
oth variables were included as covariates simultaneously.
In similar fashion, we evaluated the association of ABI
ategories with LVEDV, mass/volume ratio, and LVEF
ith linear regression. Models were adjusted as described
or LV mass. In all cases, results were similar in models 1,
, and 3; therefore we present data only for model 1.
In a sensitivity analysis, we evaluated ankle SBP as the
redictor variable of interest in place of ABI and adjusted for
he identical covariates as described in the preceding text, while
orcing brachial blood pressure into the model. This was done
ecause previous studies have evaluated the test characteristics
f ankle SBP for MAC, and to our knowledge, similar data are
ot available for a high ABI (5). In addition, we performed
ensitivity analysis, wherein LV mass was adjusted for height
nd weight rather than body surface area. In all cases, results
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January 26, 2010:342–9 High Ankle Brachial Index and LV Massere similar; so data presentation is limited to LV mass
ndexed to body surface area.
All statistical analyses were conducted with STATA version
.2 for Windows (StataCorp, College Station, Texas).
esults
mong the 4,972 study participants, the mean age was 61 
0 years, and 52% were female. Thirty-nine percent were
aucasian, 26% were African-American, 22% were Hispanic,
nd 13% were Chinese. One hundred and seventy-one subjects
3%) had ABI measurements 0.90, and 53 (1%) had ABI
easurements 1.40 or incompressible lower limb arteries.
mong those in the high-ABI category, 17 subjects (32%)
ere classified as such on the basis of incompressible lower
imb arteries. The mean LV mass was 78  16 g/m2.
Compared with subjects with intermediate ABI scores
0.90 to 1.40), those with ABI scores 0.90 had higher
revalence of traditional CVD risk factors. Exceptions were
ody mass index and serum lipid levels (Table 1). In
Characteristics of MESA Participants by Ankle BTable 1 Characteristics of MESA Participan
(
Demographic data
Age (yrs) 7
Female
Race/ethnicity†
White
Black
Hispanic
Chinese
Medical history
Hypertension
Diabetes
Smoking†
Traditional and novel cardiovascular risk factors
Body mass index (kg/m2) 27
Systolic blood pressure (mm Hg) 13
Diastolic blood pressure (mm Hg) 7
Total cholesterol (mg/dl) 19
LDL cholesterol (mg/dl) 12
HDL cholesterol (mg/dl) 5
Triglycerides (mg/dl)§ 117
C-reactive protein (mg/l)§ 2.9
eGFR (ml/min/1.73 m2) 7
Urine albumin/creatinine (mg/g)§ 9
Markers of subclinical atherosclerosis
Common carotid intima-media thickness (mm) 1.0
Internal carotid intima-media thickness (mm) 1.6
CAC prevalence
CAC severity§ 196
Left ventricular mass (g/m2) 8
Values are mean  SD or percentages unless otherwise specified. *p
†Evaluated by Fisher exact test. ‡p 0.05 compared with the ABI 0.90 to
Limited to subjects with coronary artery calcification (CAC) 0.
eGFR  estimated glomerular filtration rate; HDL  high-density
Atherosclerosis.ontrast, subjects with high ABI were older; more fre- tuently male and diabetic; and had higher SBP and CRP
evels and more advanced kidney disease yet also had lower
otal and LDL cholesterol levels, on average. Both low- and
igh-ABI groups had more subclinical atherosclerosis by
ommon and internal cIMT and CAC scores compared
ith subjects with intermediate ABI scores. Men were more
ikely to have high ABI and had greater prevalence of
ubclinical atherosclerosis by each measure. Both extreme
BI groups had higher LV mass in unadjusted analysis.
In models adjusted for age, sex, race/ethnicity, and field
enter site, subjects with either low or high ABI had a
ignificantly higher LV mass compared with subjects with
ntermediate ABI scores (Table 2). When adjusted for
raditional CVD risk factors, kidney function, and CRP, the
ssociation of low ABI with LV mass was attenuated more
o than the association of high ABI with LV mass, yet both
xtreme ABI groups remained statistically significantly as-
ociated with higher LV mass. When models were further
djusted for common and internal cIMT and CAC score,
ial Index CategoriesAnkle Brachial Index Categories
0
71)
0.90–1.40
(n  4,748)
>1.40/Incompressible
(n  53)
* 61 10 66 10*
52% 34%*
* 39% 47%
* 25% 17%
* 22% 30%
* 13% 6%
* 41% 53%
* 12% 28%*
* 12% 6%
.1 27.7 4.9 28.7 5.6
9* 125 21 132 20‡
2 72 10 70 10
6 194 35 182 36‡
4 117 31 107 28‡
5 51 15 49 17
169) 111 (77–161) 104 (86–144)
5.9)* 1.8 (0.8–4.0) 2.9 (1.2–6.2)*
1* 80 16 77 19‡
1)* 5 (3–10) 7 (4–18)‡
.23* 0.85 0.18 0.96 0.24*
.80* 1.02 0.55 1.31 0.76‡
* 47% 68%*
258)* 74 (19–278) 269 (82–1,027)*
1* 78 16 90 22*
1 compared with the ankle brachial index (ABI) 0.90 to 1.40 category.
tegory. §Median (interquartile range)—evaluated by Kruskal-Wallis test.
tein; LDL  low-density lipoprotein; MESA  Multi-Ethnic Study ofrachts by
<0.9
n  1
0 9
54%
35%
45%
13%
7%
70%
27%
26%
.4 5
9 2
1 1
7 3
0 3
0 1
(82–
(1.0–
4 2
(4–2
2 0
3 0
82%
(68–
4 2
 0.0
1.40 cahe association of low ABI with LV mass was further
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High Ankle Brachial Index and LV Mass January 26, 2010:342–9ttenuated and was rendered no longer statistically signifi-
ant. In contrast, adjustment of these variables had only a
inor effect on the association of high ABI with LV mass,
uch that subjects with high ABI had 6 g/m2 higher LV
ass compared with the intermediate ABI group, despite
djustment for traditional CVD risk factors, kidney func-
ion, CRP, and subclinical atherosclerosis (Fig. 1).
Results were similar in sensitivity analyses in which ankle
BP was evaluated as the predictor variable of interest
nstead of ABI (Fig. 2). Results were also qualitatively
imilar when a cut-point 1.00 was used to define low ABI
nd a cut-point of 1.30/incompressible was used to define
igh ABI. In this sensitivity analysis, in the final multiva-
iable model adjusting for CVD risk factors, kidney func-
ion, CRP, and subclinical atherosclerosis markers (Model
), there was no association of ABI 1.00 with LV mass
beta  0.13; 95% confidence interval: 1.29 to 1.03),
hereas the ABI 1.30 group had significantly higher LV
ass (beta  3.41; 95% confidence interval: 1.50 to 5.33).
We compared the relative strength of the association of
igh ABI with other established risk factors for LV mass by
omparing beta coefficients in linear regression models. The
ssociation of high ABI with LV mass was of a magnitude
Associations of Ankle Brachial Index CategoriesTable 2 Associations of Ankle Brachial Inde
<0.90
(n  171)
Model 1* 5.33 (3.16 to 7.50);0.001
Model 2† 2.70 (0.65 to 4.75); 0.010
Model 3‡ 1.24 (0.84 to 3.33); 0.24
Values are  (in g/m2) (95% confidence interval); p value. *Adjusted f
hypertension, diabetes, smoking, systolic blood pressure, total choles
protein), estimated glomerular filtration rate, ln(urine albumin/creati
thickness (cIMT), internal cIMT, and natural log-transformed coronary
Figure 1 Association of the Spectrum of Ankle Brachial Index W
for Demographic Data, Traditional Cardiovascular Dise
Model 1: adjusted for age, sex, race/ethnicity, and field center site. Model 2: adju
sure, total cholesterol, low-density lipoprotein cholesterol, natural log-transformed
albumin/creatinine). Model 3: adjusted for Model 2 variables and common carotid
artery calcification.imilar to that of prevalent hypertension, approximately 2.5
imes stronger than that of prevalent diabetes and 2 to 3
imes stronger than that of cIMT and CAC in models
djusted for age, sex, race/ethnicity, and field center site
Table 3).
Next, we investigated the association of high ABI with
ther parameters of LV morphology and function. High
BI was associated with higher LVEDV to a similar degree
s LV mass (Table 4). Thus, the association of high ABI
ith LV mass/volume ratio (a marker of concentric LV
emodeling) was near unity. Similarly, we observed no
ignificant association of high ABI with LVEF. For each
omparison, results were similar when models were adjusted
or all traditional CVD risk factors and further adjusted for
he measures of subclinical atherosclerosis (data not shown).
iscussion
e demonstrate a strong cross-sectional association of high
BI measurements with greater LV mass in an ethnically
iverse community-living population without clinical CVD.
e observed a graded relationship between higher ABI
cores and greater LV mass that was not materially affected
Left Ventricular Masstegories With Left Ventricular Mass
kle Brachial Index
0.90–1.40
(n  4,748)
>1.40/incompressible
(n  53)
Reference 8.52 (4.72 to 12.32);0.001
Reference 6.84 (3.22 to 10.47);0.001
Reference 6.01 (2.36 to 9.67); 0.001
sex, race, and field center site. †Adjusted for Model 1 variables plus
w-density lipoprotein cholesterol, natural log-transformed (C-reactive
Adjusted for Model 2 variables plus common carotid intima media
alcification.
Left Ventricular Mass, With Adjustment
Risk Factors, and Subclinical Atherosclerosis
or Model 1 variables and hypertension, diabetes, smoking, systolic blood pres-
ctive protein), estimated glomerular filtration rate, natural log-transformed (urine
media thickness (cIMT), internal cIMT, and natural log-transformed coronaryWithx Ca
An
or age,
terol, loith
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January 26, 2010:342–9 High Ankle Brachial Index and LV Masshen adjusted for traditional CVD risk factors, kidney
unction, and CRP or when adjusted for measures of
ubclinical atherosclerosis in other nonperipheral arterial
eds. We observed a similar association of low ABI with LV
ass in unadjusted analysis; however, this association was
ubstantially attenuated and rendered no longer statistically
ignificant when adjusted for measures of subclinical ath-
rosclerosis. In the context of prior studies in experimental
nimals, these data suggest that high ABI might be associ-
ted with LV mass through pathways distinct from athero-
clerosis. Moreover, previous studies in humans have dem-
nstrated that high ABI identifies individuals at increased
isk for all-cause and CVD mortality, nonfatal CVD events,
nd incident CHF (8–11). Higher LV mass has also been
ssociated with these same outcomes in community-living
Figure 2 Association of the Spectrum of Ankle Blood Pressure
Blood Pressure and Demographic Data, Traditional Ca
Model 1: adjusted for brachial systolic blood pressure, age, sex, race/ethnicity, and fi
ing, total cholesterol, low-density lipoprotein cholesterol, natural log-transformed (C-rea
creatinine). Model 3: adjusted for Model 2 variables and common carotid intima medi
elative Strength of Association ofisk Factors for Left Ventricular MassTable 3 Relative Strength of As ociation ofRisk Factors for Left Ventricular Mass
Left Ventricular Mass (g/m2)
ABI 1.40/incompressible 8.52 (4.72–12.32);0.001
ABI 0.90 5.33 (3.16–7.50);0.001
CAC*
1–100 1.80 (0.82–2.78);0.001
101–300 2.53 (1.13–3.94);0.001
300 4.51 (3.08–5.94);0.001
Common cIMT (per 0.19-mm increase)† 3.02 (2.58–3.46);0.001
Internal cIMT (per 0.58-mm increase)† 1.83 (1.40–2.25);0.001
Age (10.1-yr increase)† 0.42 (0.02–0.81); 0.04
Systolic blood pressure (per 16.5-mm Hg
increase)†
4.97 (4.56–2.37);0.001
Prevalent hypertension 7.65 (6.83–8.47);0.001
Prevalent diabetes 3.36 (2.18–4.55);0.001
alues are  (in g/m2) (95% confidence interval); p value. Adjusted for age, sex, race, and field
fenter site. *Reference category was CAC score  0. †1 SD increase.
Abbreviations as in Table 1.opulations (28). Future studies are required to determine
hether higher LV mass might represent a causal interme-
iary between high ABI and CVD events.
In rodent studies, experimentally induced MAC resulted
n greater arterial stiffness and LV mass. The change in LV
ass was strongly correlated to the amount of vascular
alcium content, and this relationship was observed despite
n absence of change in mean arterial pressure or arterial
iameter, suggesting that MAC might lead to LV mass
hrough mechanisms distinct from atherosclerosis (12).
hese data are relevant here because high ABI measure-
ents are widely regarded as a marker of MAC (3–5).
ndeed, ankle SBP measurements 190 mm Hg have 90%
pecificity for characteristic X-ray patterns of MAC in
umans, albeit with poor sensitivity (approximately 50%)
5). Thus, it is possible that the association of high ABI
ith LV mass demonstrated here reflect similar biology to
hat observed in rodent models of MAC.
However, in referral populations of patients with
ymptomatic PAD, prior studies have demonstrated that
4% to 75% of subjects found to have high ABI also had
oncomitant atherosclerotic PAD when interrogated by
ther confirmatory tests (13–15). Although the coexist-
Left Ventricular Mass, With Adjustment for Brachial
ascular Disease Risk Factors, and Subclinical Atherosclerosis
ter site. Model 2: adjusted for Model 1 variables and hypertension, diabetes, smok-
rotein), estimated glomerular filtration rate, natural log-transformed (urine albumin/
ness (cIMT), internal cIMT, and natural log-transformed coronary artery calcification.
ssociations of High ABIith LV Morpholo y and FunctionTable 4 Associations of High ABIWith LV Morphology and Function
LV mass index 8.52 (4.72 to 12.32);0.001
LV end-diastolic volume 8.41 (1.16 to 15.66); 0.03
LV mass/volume ratio 0.02 (0.02 to 0.05); 0.29
LV ejection fraction 1.30 (0.55 to 3.15); 0.12
alues are  (in g/m2) (95% confidence interval); p value. Compares 53 subject with ankle brachial
ndex (ABI)1.40/incompressible with 4,748 subjects with ABI 0.90 to 1.40. Models are adjustedWith
rdiov
eld cen
ctive p
a thickor age, sex, race/ethnicity, field center site, and low ABI.
LV  left ventricular.
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High Ankle Brachial Index and LV Mass January 26, 2010:342–9nce of high ABI measurements and atherosclerotic PAD
n community-living, largely asymptomatic populations is
nknown, it remains possible that the associations of
igh ABI and LV mass might reflect the consequences of
ndetected atherosclerotic PAD. To provide insights into
his competing hypothesis, we conducted our study in a
ohort without clinically apparent CVD and took advan-
age of several measurements of subclinical atherosclero-
is in nonperipheral arterial beds. Statistical adjustment
or these measurements substantially attenuated the as-
ociation of low ABI with LV mass, perhaps because both
ow ABI and these other measures are markers of the
ame systemic disease, atherosclerosis. In contrast, ad-
ustment for markers of subclinical atherosclerosis had
elatively little effect on the association of high ABI with
V mass. These data and prior experimental animal data
re consistent with the hypothesis that high ABI might
dentify a pathologic entity distinct from atherosclerosis
nd might provide insights into novel nonatherosclerotic
athways leading to higher LV mass. The mechanisms
esponsible for this association are uncertain; however,
e hypothesize that MAC might lead to arterial stiffness
nd might contribute to more rapid reflection in the ar-
erial pulse-wave during diastole, contributing to chronic
ncreased LV after-load.
It remains possible, however, that subjects with high ABI
n our study had undetected atherosclerotic PAD despite
djustment for subclinical atherosclerosis in other arterial
eds. Moreover, despite the reported high specificity of high
nkle SBP measurements for MAC, our study did not
nclude plain radiographs of the lower limbs to confirm the
haracteristic X-ray pattern of this disease. Future studies
hat simultaneously provide X-ray characterization of pat-
erns of calcification and secondary confirmatory tests for
therosclerotic PAD are required to confirm and extend our
ndings.
tudy strengths and limitations. Strengths of this study
nclude its evaluation in a large ethnically and geographically
iverse population without clinical CVD and the simultaneous
vailability of cardiac MRI and subclinical atherosclerosis
easurements. The study also has important limitations. First,
lthough we observed a dose–response relation between in-
reasing levels of ABI and LV mass, few subjects had ABI
1.40 (n  53, 1%), the level at which risk for CVD events
as increased in prior studies. Second, as stated in the
receding text, we lack X-ray data of the lower limbs to
onfirm that subjects with high ABI had MAC; thus noncal-
ific pathology might have contributed to lower-limb arterial
tiffness, high ABI, and LV mass. Third, although extensive
tatistical adjustment was undertaken to account for athero-
clerosis in nonperipheral arterial beds, it remains possible that
ubjects with high ABI had concomitant atherosclerotic PAD.
uture studies with confirmatory test for atherosclerotic PAD
re required. This study is cross-sectional and cannot evaluate
emporality of associations. We used cut-points to define low
nd high ABI that were used in prior studies to facilitateomparisons (8–10). Our analysis demonstrated a U-shaped
elationship, and a narrower ABI range for the intermediate
roup would have captured individuals with the lowest LV
ass. However, results were similar in sensitivity analyses
here the intermediate group was limited to individuals with
BI between 1.00 and 1.30. Finally, we observed commensu-
ate increases in LV mass and LVEDV in subjects with high
BI. Results might differ in older cohorts or among persons
ith established CVD, where the spectrum of disease and time
f exposure to high ABI and/or other associated risk factors
ight have been more prolonged or severe.
onclusions
igh ABI measurements are strongly associated with
reater LV mass in community-living persons without
linical CVD. This association was not materially altered
hen adjusted for subclinical atherosclerosis in nonperiph-
ral arterial beds. Future studies are required to determine
hether high ABI might lead to greater LV mass through
onatherosclerotic pathways and whether greater LV mass
ight be a causal intermediary between high ABI measure-
ents and CVD events and heart failure.
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